The central role of this pathway was demonstrated by the finding that mice lacking both Tak1 and Tgfbr2 (or Smad4) showed reduced liver injury, fibrosis, and HCC (Yang et al., 2013). This evidence concerns the gene TGFBR2 and hepatocellular carcinoma.